TransMedics acquires EVOSS and LifeCradle technologies from Bridge to Life

TransMedics Group has acquired from Bridge to Life Ltd. the assets and intellectual property related to the EVOSS warm perfusion technology and LifeCradle cold perfusion technology for organ transplantation.

“TransMedics Group, Inc. announced today that is has acquired from Bridge to Life Ltd., assets and intellectual property related to the Ex-Vivo Organ Support System and LifeCradle Heart Preservation Transport System technologies.”prnewswire.com

• 1 source
• prnewswire.comTransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to LifeTransMedics Group, Inc.Aug 2, 2023

Summarized from public sources; check the original articles before acting on it.